Showing 131-140 of 1691 results for "".
In the Pipeline A New Image Search: PET Amyloid Imaging Agent is Yielding Results
https://practicalneurology.com/diseases-diagnoses/imaging-testing/in-the-pipeline-a-new-image-search-pet-amyloid-imaging-agent-is-yielding-results/30699/Piramal Imaging shared promising results from five studies evaluating the company's PET amyloid imaging agent (florbetaben F18*) at the 2013 Alzheimer's Association International Conference this summer.- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31204/Summary of Recent Advances and Findings in NeurologyThe 2007 American Stroke Association’s International Stroke Conference in San Francisco highlighted critical barriers in stroke management and innovative therapeutic advancements. A significant finding revealed that approximately 50% of individuals
Biomarker Testing Modalities for Alzheimer Disease
https://practicalneurology.com/videos/neurology-in-motion/biomarker-testing-modalities-for-alzheimer-disease/35432/Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses key factors physicians should consider when ordering a biomarker test and recommendations for how physicians should communicate the need for a particular test with their pThe Use of Intracranial Vessel Wall MRI for the Diagnosis of Vasculitis
https://practicalneurology.com/diseases-diagnoses/stroke/the-use-of-intracranial-vessel-wall-mri-for-the-diagnosis-of-vasculitis/37234/Jae W. Song, MD, MS, Associate Professor of Radiology at the University of Pennsylvania, Philadelphia, PA, discusses the diagnostic value of intracranial vessel wall MRI for vasculitis, as well as when clinicians should order this imaging technique and the challenges that may arise.- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31042/Antiepileptic drugs (AEDs) are increasingly associated with various metabolic bone disorders, including osteomalacia, osteoporosis, and an elevated risk of fractures. Early studies highlighted these risks in institutionalized patients, but recent research extends these findings to outpatient populat
PD GENEration and Barriers to Parkinson Diagnosis - Part 1
https://practicalneurology.com/diseases-diagnoses/movement-disorders/pd-generation-and-barriers-to-parkinson-diagnosis-part-1/30095/Chantale Branson, MD, Associate Professor of Neurology at Morehouse School of Medicine, Atlanta, GA, is a researcher working on the pivotal PD GENEration study, which aims to improve treatment options through the identification of clinically relevant genes linked to Parkinson disease. In this episodUpdate on Noninvasive Neuromodulation Devices for Headache Treatment
https://practicalneurology.com/diseases-diagnoses/headache-pain/update-on-noninvasive-neuromodulation-devices-for-headache-treatment/31283/Stewart J. Tepper, MD, Vice President of the New England Institute for Neurology and Headache, Peter McAllister, MD, FAAN, Chief Medical Officer of the New England Institute for Neurology and Headache, and Teshamae Monteith, MD, Associate Professor and Chief of the Headache Division of the DepartmenVagus Nerve Stimulation: Effects Beyond the Nervous System
https://practicalneurology.com/programs/practical-neurology/vagus-nerve-stimulation-effects-beyond-the-nervous-system/30101/Stavros Zanos, MD, PhD, Associate Professor, Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, uses neurostimulation as a means to study the nervous system and to treat diseases in which the nervous system is affected or implicated. In this episode, Dr. Zanos gives an o- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31443/June 2005 Highlights from Practical Neurology: Advances and Insights in Neurological DisordersThis June issue of Practical Neurology presents significant developments in neurology, focusing on Alzheimer's disease (AD), migraine-stroke associations, statin safety, migraine treatments, drug approval p
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31229/Recent developments in vascular disease management and neurology highlight both challenges and advancements crucial for healthcare professionals. The FDA, in collaboration with Baxter, issued a warning regarding delayed onset heparin-induced thrombocytopenia (HIT) and thrombosis (HITT) associated wi